Fc epsilon RI alpha

Fc epsilon RI alpha

Fc epsilon RI alpha 분자 정보

Molecule Name
IgE Fc receptor, alpha-subunit
분자 별명
FCER1A,FCE1A,FcERI
Drug Development Progress
임상 약물 수1
시판 약물 수1
최고 연구 개발 단계Approved
표적 별명
Fc Fragment Of IgE, High Affinity I, Receptor For; Alpha Polypeptide,FCE1A,IgE Fc receptor subunit alpha,Fc-epsilon RI-alpha,FCER1A,Fc Fragment Of IgE Receptor Ia,Fc Fragment Of IgE, High Affinity I, Receptor For,Alpha Polypeptide,Fc Epsilon Receptor Ia,FcERI,Immunoglobulin E Receptor, High-Affinity, Of Mast Cells, Alpha Polypeptide,High Affinity Immunoglobulin Epsilon Receptor Alpha-Subunit,High Affinity Immunoglobulin Epsilon Receptor Subunit Alpha,Fc IgE Receptor, Alpha Polypeptide,Fc Epsilon RI Alpha-Chain,FCER1
분자 배경
High affinity immunoglobulin epsilon receptor subunit alpha (FCER1A) is also known as Fc-epsilon RI-alpha (FcERI), IgE Fc receptor subunit alpha, FCE1A. FCER1A contains two Ig-like (immunoglobulin-like) domains. FCER1A binds to the Fc region of immunoglobulins epsilon and is a high affinity receptor. FCER1A is responsible for initiating the allergic response, which binding of allergen to receptor-bound IgE leads to cell activation and the release of mediators (such as histamine) responsible for the manifestations of allergy. The same receptor also induces the secretion of important lymphokines. FCER1A plays a central role in allergic disease, coupling allergen and mast cell to initiate the inflammatory and immediate hypersensitivity responses that are characteristic of disorders such as hay fever and asthma.

Fc epsilon RI alpha 제품 목록

Species
  • Human(3)
  • Cynomolgus(2)
  • Mouse(1)
Tag
  • Fc Tag(3)
  • His Tag(2)
  • His Tag & Avi Tag(1)
Host
  • HEK293(6)
Conjugate
  • Unconjugated(5)
  • Biotin-labeled(1)
Grade
  • RUO(6)
Low Endotoxin
  • Yes(1)
  • No(5)
You Have Viewed 1-6 Of 6 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

Asset Licensing Opportunity
Resources

임상 약물 정보

영어 이름연구 코드연구 개발 단계회사적응증임상 시험
LesigerceptYH-35324; GI-301Phase 2 ClinicalYuhan Corp
Chronic Urticaria; Hypersensitivity; Immune System Diseases; Urinary Tract Infections; Urticaria
상세

시판 약물 정보

영어 이름연구 코드연구 개발 단계회사가장 빠른 브랜드 이름가장 빠른 승인 국가가장 빠른 적응증가장 빠른 승인 회사가장 빠른 승인 날짜적응증임상 시험
Benzylpenicilloyl PolylysineApprovedAllerquest LlcPre-penUnited StatesAnaphylaxis; Diagnostic agentsAllerquest Inc1974-07-25
Anaphylaxis; Diagnostic agents
상세
Customer Reviews